IDOV-Immune

N/A

Report date: 2025/05/12 15:27:19

Base Information

Drug NameIDOV-Immune
Drug Alias NameOncolytic vaccinia virus
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsUrinary Bladder NeoplasmsProstatic NeoplasmsUterine Cervical Neoplasms +[16] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesViroMissile Inc
China Registration ClassN/A

Develop Information

Active CompaniesViroMissile Inc
Inactive CompaniesN/A
Active IndicationsUrinary Bladder NeoplasmsProstatic NeoplasmsUterine Cervical Neoplasms +[16] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A